Structure and drug binding of the SARS-CoV-2 envelope protein transmembrane domain in lipid bilayers

2020/11/11 by Venkata S. Mandala, Matthew J. McKay, A. Shcherbakov +4 · 6 citations
Biochemistry, Genetics and Molecular Biology · Chemistry · Medicine · #Advanced NMR Techniques and Applications #Infectious Encephalopathies and Encephalitis #Lipid Membrane Structure and Behavior

paper · pdf · doi:10.1038/s41594-020-00536-8

crossref issued 2020/11/11 · crossref published 2020/11/11 · crossref published-online 2020/11/11 · openalex publication_date 2020/11/11 · crossref created 2020/11/11 · crossref published-print 2020/12/01 · crossref deposited 2023/05/20 · openalex created_date 2025/10/10 · crossref indexed 2026/07/14 · openalex updated_date 2026/08/01

Citations

• Protein backbone and sidechain torsion angles predicted from NMR chemical shifts using artificial neural networks
• Coronavirus envelope protein: current knowledge

Cited by

• A comprehensive review of current insights into the virulence factors of SARS-CoV-2
• SARS-CoV-2 causes periodontal fibrosis by deregulating mitochondrial β-oxidation
• SARS‐CoV‐2 enhances lysosomal exocytosis and deacidifies lysosomes to facilitate viral release
• Programmed cell death: the pathways to severe COVID-19?
• In silico characterisation of a novel SARS-CoV-2 envelope protein inhibitor and in vitro validation against murine coronavirus
• Coronavirus, the King Who Wanted More Than a Crown: From Common to the Highly Pathogenic SARS-CoV-2, Is the Key in the Accessory Genes?